Poland
# |
Name |
Dividends Paid |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 0.00
|
Dec. 31, 2023 | USD 12.20 | -4.46% |
|
Poland |
|
2 |
USD 0.00
|
Dec. 31, 2023 | USD 1.79 | -1.96% |
|
Poland |
|
3 |
USD 0.00
|
Dec. 31, 2023 | USD 2.23 | -2.90% |
|
Poland |
|
4 |
USD 0.00
|
Dec. 31, 2023 | USD 9.53 | 2.20% |
|
Poland |
|
5 |
USD 0.00
|
Dec. 31, 2023 | USD 6.53 | 2.36% |
|
Poland |
|
6 |
USD 0.00
|
Dec. 31, 2023 | USD 10.51 | -3.97% |
|
Poland |
The Clinical Trials company in Poland with the highest Dividends Paid is Captor Therapeutics Spolka Akcyjna (Warsaw Stock Exchange: CTX.WA) at USD 0.00.
The Clinical Trials company in Poland with the lowest Dividends Paid is Selvita S.A. (Warsaw Stock Exchange: SLV.WA) at USD 0.00.
The top 10 Clinical Trials companies in Poland by Dividends Paid are Captor Therapeutics Spolka Akcyjna, Medinice S.A., Molecure S.A., Poltreg S.A., Ryvu Therapeutics S.A. and Selvita S.A..
The bottom 10 Clinical Trials companies in Poland by Dividends Paid are Selvita S.A., Ryvu Therapeutics S.A., Poltreg S.A., Molecure S.A., Medinice S.A. and Captor Therapeutics Spolka Akcyjna.